Actively Recruiting
Suprascapular Nerve Block and Proprioception in Hemiplegic Shoulder Pain: A Randomized Controlled Study
Led by Fatih Sultan Mehmet Training and Research Hospital · Updated on 2026-01-21
40
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this prospective randomized controlled clinical trial is to evaluate the effect of suprascapular nerve block on shoulder joint proprioception in stroke patients with hemiplegic shoulder pain. Fourteen patients aged 18-80 years with hemiplegic shoulder pain will be randomized into two groups. One group will receive suprascapular nerve block followed by a standardized physical therapy program, while the control group will receive the same physical therapy program alone. The primary outcome is shoulder joint proprioception. Secondary outcomes include pain intensity, shoulder range of motion, motor recovery, stroke-specific quality of life, and upper extremity functional outcomes. The results of this study are expected to clarify the role of suprascapular nerve block on proprioception and rehabilitation outcomes in patients with hemiplegic shoulder pain.
CONDITIONS
Official Title
Suprascapular Nerve Block and Proprioception in Hemiplegic Shoulder Pain: A Randomized Controlled Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 80 years
- Presence of shoulder pain on the hemiplegic side with a Numeric Rating Scale (NRS) score > 3
- At least 1 month since the cerebrovascular event (subacute and chronic stroke patients)
- Active shoulder flexion range of motion > 90 degrees (required for the application of the laser pointer-assisted joint position sense test)
- First-ever, unilateral hemiplegia
You will not qualify if you...
- Mini-Mental State Examination score < 24 indicating cognitive impairment
- Presence of aphasia
- Shoulder spasticity with a Modified Ashworth Scale score > 2
- Brunnstrom upper extremity motor stage < 3
- Botulinum toxin type A injection within the last 3 months to muscles affecting shoulder joint movement (trapezius, levator scapulae, pectoralis major, deltoid, serratus anterior, latissimus dorsi, rhomboids, teres major, biceps, coracobrachialis, triceps, supraspinatus, subscapularis, infraspinatus, and teres minor)
- Pre-existing shoulder pathology causing pain in the hemiplegic shoulder
- Presence of neglect syndrome
- Complex regional pain syndrome, central pain, traumatic brachial plexus injury
- Change in pain medication during the study period
- Hypersensitivity to the medication used for suprascapular nerve block (lidocaine)
- Adhesive capsulitis (frozen shoulder)
- Other shoulder pathologies such as fractures or joint replacement
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fatih Sultan Mehmet Training and Research Hospital Istanbul, İstanbul, Turkey
Istanbul, Istanbul, Turkey (Türkiye), 34752
Actively Recruiting
Research Team
M
Merve Kocibar, MD
CONTACT
E
Esra Giray, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here